158 related articles for article (PubMed ID: 17760415)
1. Radiolabeling of bombesin-like peptide with 99mTc: 99mTc-litorin and biodistribution in rats.
Durkan K; Lambrecht FY; Unak P
Bioconjug Chem; 2007; 18(5):1516-20. PubMed ID: 17760415
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, radiolabelling and biological characteristics of a bombesin peptide analog as a tumor imaging agent.
Okarvi SM; al-Jammaz I
Anticancer Res; 2003; 23(3B):2745-50. PubMed ID: 12894569
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
Okarvi SM; Al Jammaz I
Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a series of new 99mTc-labeled bombesin-like peptides for early cancer detection.
Gourni E; Paravatou M; Bouziotis P; Zikos C; Fani M; Xanthopoulos S; Archimandritis SC; Livaniou E; Varvarigou AD
Anticancer Res; 2006; 26(1A):435-8. PubMed ID: 16475730
[TBL] [Abstract][Full Text] [Related]
5. Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours.
Ferro-Flores G; Arteaga de Murphy C; Rodriguez-Cortés J; Pedraza-López M; Ramírez-Iglesias MT
Nucl Med Commun; 2006 Apr; 27(4):371-6. PubMed ID: 16531924
[TBL] [Abstract][Full Text] [Related]
6. A new high affinity technetium-99m-bombesin analogue with low abdominal accumulation.
Lin KS; Luu A; Baidoo KE; Hashemzadeh-Gargari H; Chen MK; Brenneman K; Pili R; Pomper M; Carducci MA; Wagner HN
Bioconjug Chem; 2005; 16(1):43-50. PubMed ID: 15656574
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of (99m)Tc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines.
Yurt Lambrecht F; Durkan K; Ozgür A; Gündüz C; Avcı CB; Susluer SY
J Drug Target; 2013 May; 21(4):383-8. PubMed ID: 23301856
[TBL] [Abstract][Full Text] [Related]
8. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D
Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305
[TBL] [Abstract][Full Text] [Related]
9. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
Kunstler JU; Veerendra B; Figueroa SD; Sieckman GL; Rold TL; Hoffman TJ; Smith CJ; Pietzsch HJ
Bioconjug Chem; 2007; 18(5):1651-61. PubMed ID: 17663527
[TBL] [Abstract][Full Text] [Related]
10. Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation.
Koumarianou E; Mikołajczak R; Pawlak D; Zikos X; Bouziotis P; Garnuszek P; Karczmarczyk U; Maurin M; Archimandritis SC
Nucl Med Biol; 2009 Aug; 36(6):591-603. PubMed ID: 19647165
[TBL] [Abstract][Full Text] [Related]
11. Targeted imaging of gastrin-releasing peptide receptors with 99mTc-EDDA/HYNIC-[Lys3]-bombesin: biokinetics and dosimetry in women.
Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Pichardo-Romero PA
Nucl Med Commun; 2008 Aug; 29(8):741-7. PubMed ID: 18753829
[TBL] [Abstract][Full Text] [Related]
12. Radiochemical and radiobiological assessment of a pyridyl-S-cysteine functionalized bombesin derivative labeled with the (99m)Tc(CO)3(+) core.
Bouziotis P; Gourni E; Patsis G; Psimadas D; Zikos C; Fani M; Xanthopoulos S; Loudos G; Paravatou-Petsotas M; Livaniou E; Varvarigou AD; Pirmettis I; Papadopoulos M
Bioorg Med Chem; 2013 Nov; 21(21):6699-707. PubMed ID: 24035515
[TBL] [Abstract][Full Text] [Related]
13. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
Faintuch BL; Teodoro R; Duatti A; Muramoto E; Faintuch S; Smith CJ
Nucl Med Biol; 2008 May; 35(4):401-11. PubMed ID: 18482677
[TBL] [Abstract][Full Text] [Related]
14. Phase I trial of technetium [Leu13] bombesin as cancer seeking agent: possible scintigraphic guide for surgery?
De Vincentis G; Scopinaro F; Varvarigou A; Ussof W; Schillaci O; Archimandritis S; Corleto V; Longo F; Delle Fave G
Tumori; 2002; 88(3):S28-30. PubMed ID: 12365378
[TBL] [Abstract][Full Text] [Related]
15. Improved radiopharmaceutical based on 99mTc-Bombesin-folate for breast tumour imaging.
Aranda-Lara L; Ferro-Flores G; Ramírez Fde M; Ocampo-García B; Santos-Cuevas C; Díaz-Nieto L; Isaac-Olivé K
Nucl Med Commun; 2016 Apr; 37(4):377-86. PubMed ID: 26657220
[TBL] [Abstract][Full Text] [Related]
16. New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors.
García Garayoa E; Schweinsberg C; Maes V; Rüegg D; Blanc A; Bläuenstein P; Tourwé DA; Beck-Sickinger AG; Schubiger PA
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):42-50. PubMed ID: 17372572
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two peptide radiotracers for prostate carcinoma targeting.
Faintuch BL; Oliveira EA; Nunez EG; Moro AM; Nanda PK; Smith CJ
Clinics (Sao Paulo); 2012; 67(2):163-70. PubMed ID: 22358242
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of bombesin peptide derivatives as potential tumor imaging agents: effects of structure and composition of amino acid sequence on in vitro and in vivo characteristics.
Okarvi SM; Jammaz IA
Nucl Med Biol; 2012 Aug; 39(6):795-804. PubMed ID: 22381782
[TBL] [Abstract][Full Text] [Related]
19. A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent.
La Bella R; Garcia-Garayoa E; Bahler M; Bläuenstein P; Schibli R; Conrath P; Tourwé D; Schubiger PA
Bioconjug Chem; 2002; 13(3):599-604. PubMed ID: 12009951
[TBL] [Abstract][Full Text] [Related]
20. Lys3-bombesin conjugated to 99mTc-labelled gold nanoparticles for in vivo gastrin releasing peptide-receptor imaging.
Mendoza-Sánchez AN; Ferro-Flores G; Ocampo-García BE; Morales-Avila E; de M Ramírez F; De León-Rodríguez LM; Santos-Cuevas CL; Medina LA; Rojas-Calderón EL; Camacho-López MA
J Biomed Nanotechnol; 2010 Aug; 6(4):375-84. PubMed ID: 21323111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
